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Does pain acceptance predict physical and psychological outcomes in cancer outpatients with pain?
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Abstract
Pain acceptance has been associated with
improved physical and psychosocial well-being
in chronic non-malignant pain patients.
However, its effects are unclear in cancer out-
patients with pain. Our aim was to determine
whether pain acceptance predicts reduced
pain, pain interference with function, anxiety,
and depression in cancer outpatients. We
recruited 116 outpatients from a tertiary oncol-
ogy center, with various types of cancer and
pain levels. Patients completed the Brief Pain
Inventory, the Hospital Anxiety and Depression
Scale and the Chronic Pain Acceptance
Questionnaire, the latter of which comprises
activity engagement and pain willingness. We
carried out multiple regression analyses,
adjusting for patient characteristics and out-
comes. Activity engagement and pain willing-
ness significantly predicted pain interference
with function (P=0.033 and P=0.041 respec-
tively). However, only activity engagement pre-
dicted anxiety (P=0.001) and depression
(P<0.001). These findings support the benefi-
cial role of pain acceptance in patients’ func-
tional adaptation to cancer-related pain.
Activity engagement in particular, shows
promise in fostering psychological well-being.
Further studies could confirm its role in reduc-
ing anxiety and depression in cancer patients
with pain and whether it should be included in
cancer pain management interventions.
Further studies could confirm its role in reduc-
ing anxiety and depression in cancer patients
with pain, and whether it should be included in
cancer pain management interventions.
Introduction
Aspects of cancer pain, such as increasing
intensity and duration, have been linked to
diminished quality of life, poor functioning
and psychological distress, regardless of differ-
ences in measurement and type of patients.1-3
Pain acceptance could help cancer patients
adapt to pain, since it has proven valuable in
determining physical and emotional adjust-
ment to chronic non-malignant pain.vPain
acceptance refers to the continuation of activi-
ties despite experiencing pain, as well as the
willingness to accept the presence of pain in
order to discontinue futile attempts to control
it and live a satisfying life.4 Acceptance has
been associated with improved emotional,
physical and social functioning in chronic pain
sufferers.5,6 However, several studies have
found no significant association between
acceptance and pain intensity or physical func-
tioning.7-9
Similarities in pain, activity and emotional
distress between cancer and chronic non-can-
cer patients provide ground for exploration of
the impact of the psychological therapeutic
construct of acceptance within the context of
cancer pain. To our knowledge, only one quan-
titative study has investigated pain acceptance
in a cancer population. Gauthier et al.10 report-
ed an association between pain acceptance
and psychological well-being in patients with
advanced cancer, but no association with pain
or physical function. This finding has impor-
tant implications, especially given that cancer
patients frequently experience co-morbid pain
and depression,2 two factors that react to one
another and share common biological path-
ways.11 The neurotransmitter imbalance
occurring in depression is associated with
greater sensitivity to pain and changes in pain
perception.11,12 However, the direction of
causality between pain and depression
remains unspecified,13 and it is possible that
activity restriction may mediate the pain-
depression relationship.14-16 Additionally, evi-
dence of the association between cancer pain
and anxiety is limited; it is unclear whether
anxiety exists due to variables occurring main-
ly in outpatient settings, such as waiting for
procedures or test results.17,18 Studies have
reported that patients’ functional status and
life disruption are critical in predicting abnor-
mal anxiety levels.17,19
In light of these findings, we wished to fur-
ther explore the effect of acceptance on physi-
cal and psychological well-being. Our aim was
to determine whether pain acceptance predicts
pain, pain-related functional interference,
anxiety and depression in cancer outpatients.  
Materials and Methods
Ethics approval was obtained from the
University of Surrey Faculty of Arts and Human
Sciences Ethics Committee and the Cyprus
Bioethics Committee. Participants were con-
secutive outpatients at the day care center of
the Bank of Cyprus Oncology Centre (BOCOC)
in Cyprus, attending for chemotherapy and
maintenance drug administration or doctor
appointments. Eligible participants were over
18 years of age, with any type of cancer and
any level of cancer pain. 
We recruited a sample of 145 consecutive
cancer outpatients at the day care center in
August 2010, of which 4 (3%) were excluded
due to incomplete responses, and 35 (24%)
were excluded because they experienced no
cancer-related pain. Outpatients gave their
informed consent, completed the question-
naires and returned them to the researcher
(EP). After completion of the questionnaires,
the researcher debriefed participants about
the purpose of the study and the assessment
measures used.
All assessment measures and forms were
translated from English to Greek, and verified
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for grammar and comprehension. An inde-
pendent translator then translated the forms
and questionnaires back from Greek to
English. There were virtually no differences
between the original versions and the back
translation. Participants were given either
English or Greek questionnaires depending on
the language they felt most comfortable with.MeasuresDemographic and medical factors
Demographic variables recorded for each
participant included age, sex, family situation,
educational level, work status and nationality.
Reported medical factors included disease and
treatment information such as primary cancer
site, presence of metastasis, illness duration,
pain location, cancer treatment and pain treat-
ment. The level of pain treatment was coded
according to the World Health Organization
(WHO) analgesic ladder.20 Therefore, pain
treatment was coded as none, Paracetamol/
NSAIDs, weak opioids and strong opioids. We
also dichotomised pain treatment as treatment
received or not. 
Pain assessment
The Brief Pain Inventory (BPI)21 was used
to assess two main dimensions; pain severity
(sensory dimension) and pain interference
with several aspects of daily functioning (reac-
tive dimension). The short-form version (BPI-
SF) used in this study assesses worst and least
pain in the past 24 hours, average pain, and
pain experienced at the time of questionnaire
completion on an 11-point rating scale (0-10)
with the anchors no pain and pain as bad as
you can imagine. In addition, pain interference
with general activity, mood, walking ability,
normal work, relations with others, sleep and
life enjoyment is rated on an 11-point rating
scale with the anchors does not interfere and
completely interferes. Scores of the 4 items
measuring worst, least, average and current
pain are added-up and divided by the number
of items in order to calculate total pain severi-
ty. The scores of the 7 interference items are
also added up and divided by the number of
items to calculate total pain interference. Total
pain severity and total pain interference scores
range from 0-10. Cronbach’s alpha for the
Severity and Interference scales was 0.88 and
0.93 respectively.
Psychological distress 
Anxiety and depression levels were meas-
ured with the Hospital Anxiety and
Depression scale, a screening tool with the
purpose of identifying co-morbid anxiety and
depression in populations found in medical
settings.22 The HAD scale focuses on non-
somatic symptoms of anxiety and depression,
such as autonomic anxiety and unhedonia.
The scale consists of 14 items; 7 items for the
anxiety subscale and 7 for the depression
subscale. Each item is scored on a 4-point
scale ranging from 0-3, yielding a total score
of 0-21 for each subscale. Cronbach’s alpha
for the Anxiety and Depression scales was
0.85 and 0.79 respectively.
Acceptance 
The Chronic Pain Acceptance Questionnaire
(CPAQ)23 measures the degree to which the
patient accepts pain as a part of daily life and
carries on with general activities as normal.
The revised 20-item version was used in the
present study.24 The CPAQ questionnaire con-
sists of two subscales; Activity Engagement
and Pain Willingness. Activity Engagement
refers to the continuation of activities as nor-
mal even if experiencing pain, whereas Pain
Willingness refers to the individual’s willing-
ness, as opposed to reluctance, to experience
pain without futile attempts to control it. Each
item of the questionnaire is rated on a 7-point
rating scale ranging from 0-6, depending on
the extent to which each statement applies to
the participant (e.g. 0=never true and
6=always true). Scores for Activity
Engagement range from 0 to 66 and for Pain
Willingness from 0 to 54. Cronbach’s alpha for
the Activity Engagement and Pain Willingness
subscales was 0.83 and 0.84 respectively.Statistical analysis
Data were screened for accuracy, missing
values and normal distribution. They were not
normally distributed, therefore we carried out
non parametric univariate analyses.
Demographic, disease and treatment char-
acteristics were collected to describe the sam-
ple. Univariate analyses such as Mann-
Whitney U, Kruskall-Wallis H and Spearman’s
correlations were carried out where appropri-
ate to assess the relationship between sample
characteristics and assessment measures.
Patient characteristics and outcome variables
that were significantly associated with other
patient outcomes and the acceptance sub-
scales at 0.05 in univariate analyses were
included in the multiple regression model.
Multicollinearity was tested by examining val-
ues of Tolerance and Variance Inflation Factor
(VIF). Data were analyzed using SPSS
(Statistical Package for the Social Sciences;
Chicago, IL, USA) v.21.0.1.
Results Patient characteristics
Of the 116 participants included in the
study (Table 1) the majority were female
(76.7%), married (83.6%) and of Greek
Cypriot nationality (89.7%). Ages ranged from
18 to 79 years (M=56.23, SD=12.26). 
Participants’ medical characteristics
revealed that breast cancer was the most com-
mon diagnosis (52.6%) and that 43 (37.1%)
patients had metastatic disease. Cancer dura-
tion ranged from 1 month to 22 years
(M=39.21 months, SD=52.91). The most fre-
quently reported pain locations were the
chest (31.9%), abdomen (29.3%) and back
(21.6%). Most participants were receiving
cancer treatment (81.9%) and Paracetamol/
Non-steroidal anti-inflammatory drugs
(38.8%), while 52.5% of patients reported
receiving no pain medication despite indicat-
ing that they experienced pain. Pain treat-
ment was classified according to guidelines
for cancer pain relief by the World Health
Organization.20Univariate analysesAcceptance
Univariate non parametric analyses were
carried out in order to detect any significant
associations between patient characteristics
and acceptance subscales. Participants who
were working had significantly higher activ-
ity engagement scores (P=0.027) compared
to those not working. Patients’ primary can-
cer site influenced their activity engagement
scores (P=0.009). Gynecological/genitouri-
nary cancers had the lowest activity engage-
ment scores (29.56±15.45). Pain in the
abdomen was associated with lower activity
engagement (P=0.044). Patients receiving
pain treatment had significantly lower activ-
ity engagement (P=0.005). Pain willingness
was not associated with patient characteris-
tics.
Patient outcomes
Further univariate analyses identified
associations between patient characteristics
and outcome measures. 
A higher education level was associated
with lower pain (r=-0.228, P=0.014), anxiety
(r=-0.287, P=0.002) and depression (R=-
0.189, P=0.042) scores. Participants who
were working had significantly lower anxiety
(P=0.044) and depression scores (P=0.019),
compared to those not working. Patients’ pri-
mary cancer site influenced their pain inter-
ference (P=0.008), depression (P=0.004) and
activity engagement scores (P=0.009).
Gynecological/genitourinary cancers had the
highest mean pain interference scores
(5.82±2.68), while lung cancer patients had
the highest depression scores (12.00± 3.94).
Back pain was associated with higher pain
severity (P=0.45), as was pain in the
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abdomen (P=0.031). Patients with 2-4 pain
sites had higher pain severity (P=0.41) and
pain interference scores (P=0.42). Patients
receiving pain treatment had significantly
higher scores of pain severity (P=0.014), pain
interference (P=0.013), anxiety (P<0.001),
and depression (P<0.001).Bivariate associations between painacceptance and physical and psy-chological outcomes
Spearman’s correlations (Table 2) revealed
that activity engagement was significantly cor-
related with pain severity, pain interference,
anxiety and depression. Pain willingness was
weakly correlated with pain severity and pain
interference. 
Linear multiple regression: role of acceptance subscales in predictingoutcomes
Multiple regression was used to determine
the extent to which Activity Engagement and
Pain Willingness predict physical and psycho-
logical outcomes. Patient demographic and
medical characteristics significant at P<0.05
were included in the model when associated
with the outcome variable, or both the predic-
tor and outcome. Neither acceptance subscale
predicted pain severity. 
Activity engagement and pain willingness,
together with gynecological/genitourinary can-
cer, pain severity and depression accounted for
59% of the variance in pain interference with
function, [F(8,107)=18.94, P<0.001] (Table 3).
Activity engagement, in addition to educa-
tion, pain treatment and interference,
accounted for 33% of the variance in anxiety
[F(6,109)=8.89, P<0.001] (Table 4).
Activity engagement, together with lung
cancer site, pain treatment and pain interfer-
ence accounted for 56% of the variance in
depression scores [F(7,108)=19.71, P<0.001]
(Table 5). 
Discussion
The aim of the present study was to investi-
gate the role of pain acceptance in physical
and functional outcomes (pain interference
with daily life) and psychological (anxiety and
depression) outcomes in a sample of outpa-
tients with cancer pain. The activity engage-
ment subscale of the acceptance measure pre-
dicted pain interference, anxiety, and depres-
sion. The pain willingness subscale predicted
only pain interference and not the psychologi-
cal outcomes of anxiety and depression.
Neither acceptance subscale played a role in
predicting pain severity. Our findings replicate
and extend those of the only previous study we
are aware of investigating the role of accept-
ance in a cancer population.10 We replicate the
finding that greater activity engagement pre-
dicts better psychological outcomes. We extend
this previous research with our finding that
both pain willingness and activity engagement
seem to play a role in the extent to which pain
interferes with everyday functioning. It should
be noted that, outside of the cancer literature,
most acceptance studies have found associa-
tions between physical and psychosocial func-
tioning with both acceptance subscales and
with overall acceptance.6,8,9,25
                             Article
Table 1. Sample characteristics (N=116).
                                                                                            Mean±SD (frequency) 
Age (range: 18-79)                                                                                                         56.23±12.26 
Sex                                                                                                                                               
Male                                                                                                                             27 (23.3%)
Female                                                                                                                         89 (76.7%)
Ethnicity                                                                                                                                     
Greek/Greek-Cypriot                                                                                               102 (87.9%)
Other                                                                                                                            14 (12.1%)
Education                                                                                                                                   
Primary school                                                                                                           28 (24.1%)
High school                                                                                                                 54 (46.6%)
College/university                                                                                                     34 (29.3%)
Work status                                                                                                                               
Employed (full/part-time)                                                                                      40 (34.5%)
Not working (unemployed/ homemaker/retired/ student)                             51 (44.0%)
Not working due to illness (on sick leave/medical retirement)                   25 (21.6%)
Marital status                                                                                                                            
Married/co-habiting                                                                                                  97 (83.6%)
Single/separated/widowed                                                                                     19 (16.4%)
Primary cancer site                                                                                                                 
Breast                                                                                                                           61 (52.6%)
Gastrointestinal                                                                                                        24 (20.7%)
Lung                                                                                                                               9 (7.8%)
Gynaecologic/genito-urinary                                                                                    11 (9.5%)
Other                                                                                                                            11 (9.5%)
Cancer duration, months (range: 1-264)                                                                 39.21±52.91
Metastasis                                                                                                                   43 (37.1%)
No metastasis                                                                                                            73 (62.9%)
Cancer treatment                                                                                                      96 (82.8%)
No cancer treatment                                                                                                20 (17.2%)
Cancer treatment                                                                                                                    
Chemotherapy                                                                                                           70 (60.3%)
Targeted therapy ± chemotherapy                                                                       21 (18.1%)
Radiotherapy ± chemotherapy                                                                               4 (3.4%)
No cancer treatment                                                                                                21 (18.1%)
Pain site (multi-response variable)                                                                                    
Head and neck                                                                                                           12 (10.3%)
Chest                                                                                                                            37 (31.9%)
Back                                                                                                                               25 (21.6%
Abdomen                                                                                                                     34 (29.3%)
Pelvic region                                                                                                                 6 (5.2%)
Upper limbs                                                                                                                12 (10.3%)
Lower limbs                                                                                                                20 (17.2%)
Bones                                                                                                                             7 (6.0%)
Unknown                                                                                                                        5 (4.3%)
No. of reported pain sites                                                                                                    
1                                                                                                                                     76 (65.5%)
2-4                                                                                                                                 35 (30.2%)
Pain treatment (highest WHO class of analgesics reported)                                       
None                                                                                                                            59 (50.9%)
Paracetamol/NSAIDs                                                                                                 45 (38.8%)
Weak opioids                                                                                                                2 (1.7%)
Strong opioids                                                                                                             10 (8.6%)
Pain treatment                                                                                                               57 (49.1%)
No pain treatment                                                                                                          59 (50.9%)
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Thus, our findings support the growing con-
sensus that acceptance is associated with
improved emotional, physical, and social func-
tioning in the wider pain literature.5,9 This is
of substantial interest given that acceptance
appears to be a modifiable construct that is
amenable to intervention. A recent systematic
review and meta-analysis of acceptance-based
interventions for the treatment of chronic pain
found that acceptance-based interventions
across different chronic pain populations
improve both pain intensity and physical well-
being, as well as depression, anxiety, and qual-
ity of life.26 The authors did not break down the
analysis by acceptance subscales, but our find-
ings suggest that focusing interventions on
continuing activities as normal despite pain
will be most useful for improving both physical
and psychological outcomes, at least in cancer
patients. Our findings also suggest that inter-
ventions which focus on being willing  to expe-
rience pain without futile attempts to control it
may also be useful for improving the extent to
which pain interferes with everyday living, but
possibly not for improving psychological well-
being. Perhaps the willingness to experience
pain is unrealistic in cancer patients, especial-
ly since cancer pain could signify tumor growth
and disease progression.27 Most research con-
cerning acceptance applies to chronic pain
populations, and although the same physiolog-
ical mechanisms may be involved in both can-
cer pain and non-malignant pain,28 it cannot
be ignored that tumor-related factors or indi-
vidual response to cancer treatment are likely
to affect cancer patients’ physical and psy-
chosocial functioning. The fact that the sever-
ity of cancer pain was not associated with
acceptance measures in multivariate analyses
also, perhaps, suggests that acceptance-based
interventions may be effective whatever level
of cancer pain is being experienced. However,
this hypothesis awaits testing. 
Activity engagement, but not pain willing-
ness, was also associated with certain patient
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Table 2. Descriptive statistics and correlation matrix of measures.
                                          Mean±SD              BPI -                   BPI -                 HADS-                    HADS-                              CPAQ- 
                                                                      severity          interference          anxiety                depression               activity engagement
BPI severity                                   3.33±1.83                                                                                                                                                                                       
BPI interference                         3.95±2.51                    0.618*                                                                                                                                                         
                                                                                            P<0.001                                                                                                                                                            
HADS - anxiety                              7.61±4.48                    0.310*                       0.424*                                                                                                                        
                                                                                             P=0.001                    P<0.001                                                                                                                         
HADS - depression                     6.51±4.18                    0.363*                       0.546*                       0.662*                                                                                       
                                                                                            P<0.001                    P<0.001                    P<0.001                                                                                       
CPAQ - activity engagement    42.08±13.57                 -0.252*                      -0.432*                      -0.483*                            -0.571*                                               
                                                                                             P=0.006                    P<0.001                    P<0.001                          P<0.001                                              
CPAQ - pain willingness           18.07±11.22                   -0.182                      -0.199**                      -0.018                              -0.128                                           -0.130
                                                                                            P=0.051                    P=0.033                    P=0.850                          P=0.171                                       P=0.166
BPI, Brief Pain Inventory; HADS-A, Hospital Anxiety and Depression Scale-Anxiety; HADS-D, Hospital Anxiety and Depression Scale-Depression; CPAQ, Chronic Pain Acceptance Questionnaire. *Significant at 0.01
(two-tailed); **Significant at 0.05 (two-tailed). 
Table 3. Multiple regression with pain interference as the outcome variable.
Pain interference                           B              SE            Beta           P               95% CI for B
Predictors                                                                                                                        
Constant                                                          2.18              1.04                                     0.039                     0.11, 4.25
Gynecological/genitourinary cancer        1.39              0.56                 0.16            0.014*                    0.28, 2.49
No. of pain sites (≥2)                                  0.40              0.24                 0.11             0.097                    -0.07, 0.87
Pain treatment                                              -0.10            0.35                -0.02            0.782                    -0.79, 0.60
BPI - severity                                                  0.55              0.10                 0.40            0.00**                    0.36, 0.74
HADS - anxiety                                              0.02              0.05                 0.04             0.673                    -0.08, 0.12
HADS - depression                                       0.16              0.06                 0.27           0.007**                   0.04, 0.28
CPAQ - activity engagement                       -0.03            0.02                -0.17           0.033*                  -0.06, -0.00
CPAQ - pain willingness                               -0.03            0.02                -0.14           0.041*                  -0.06, -0.00 
*Significant at 0.05; **Significant at 0.01. 
Table 4. Multiple regression with anxiety as the outcome variable.
Predictors                                          B           SE         Beta               P              95% CI for B
Constant                                                          11.75           2.7                                      0.000                    6.40, 17.10
Education                                                       -1.07          0.52            -0.18               0.042*                   -2.1, -0.04
Work status                                                    -0.14          0.81            -0.01                 0.867                    -1.72, 1.45
Pain treatment                                               1.49           0.73             0.17                0.044*                    0.04, 2.93
BPI - severity                                                  -0.04          0.25            -0.02                 0.882                    -0.53, 0.45
BPI - interference                                         0.44           0.19             0.25                0.023*                    0.06, 0.82
CPAQ - activity engagement                         -0.1            0.03            -0.30              0.001**                 -0.16, -0.04
*Significant at 0.05; **Significant at 0.01.
Table 5. Multiple regression with depression as the outcome variable.
Predictors                                          B           SE         Beta               P              95% CI for B
Constant                                                           7.54           2.10                                     0.000                    3.38, 11.71
Education                                                       -0.43          0.40            -0.07                 0.289                    -1.21, 0.37
Work status                                                     0.51           0.61             0.06                 0.409                    -0.71, 1.73
Lung cancer                                                    3.30           1.04             0.21                0.002*                    1.24, 5.36
Pain treatment                                               1.70           0.56             0.20                0.003*                    0.59, 2.81
BPI - severity                                                 -0.06          0.19            -0.03                 0.760                    -0.43, 0.32
BPI - interference                                         0.57           0.15             0.34                0.000*                    0.28, 0.86
CPAQ - activity engagement                       -0.10          0.02            -0.32               0.000*                  -0.14, -0.05
*Significant at 0.01.
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characteristics in the present study.
Participants who were working reported high-
er activity engagement, as in studies on non-
malignant pain.4,6 It may be that a willingness
to continue as normal with activities helps
people with a cancer diagnosis to retain their
work. Alternatively, it may be that continuing
to work despite the cancer diagnosis leads to
improvements in activity engagement. Activity
engagement also varied by cancer site and
pain site, with gynecological/genitourinary
cancers and pain in the abdomen being associ-
ated with the lowest activity engagement
scores. The reason for these findings is not
known and needs to be replicated with a larger
study focused primarily upon this research
question. Additionally, participants in our
study receiving pain treatment had lower activ-
ity engagement scores, whereas McCracken
and Eccleston6 reported increased use of med-
ication in patients with lower pain willingness.
It is possible that attempts to control pain
through medical means may sit uncomfortably
alongside the notion of acceptance expressed
as continuing engagement with normal activi-
ties despite pain. It would be interesting to see
whether acceptance-based interventions are
differentially effective depending on whether
patients are also taking analgesics or not. 
This study is not without limitations. The
majority of participants were female, with
breast cancer, aged 60-69, Greek Cypriot and
married, therefore it may be difficult to gener-
alize findings. However, results are mainly
consistent with studies in diverse cultural pop-
ulations despite variability in assessment
measures, suggesting that cancer pain and
psychological co-morbidity are universal fac-
tors. Due to the cross-sectional study design,
data were collected at one point in time in the
form of self-report measures, engendering the
possibility of discrepancy between reported
results and actual behavior. Despite this,
patients’ subjective perception of pain, dis-
tress and behavior were of primary research
interest. Effects of fatigue, insomnia, appre-
hension about the diagnosis or medical visit
and effects of pharmacological treatments may
have possibly occurred at varying degrees dur-
ing questionnaire completion. It is also diffi-
cult to assess psychological health especially
when there is confusion between normal sad-
ness due to physical illness and abnormal clin-
ical depression.29 Depressive symptoms exist
in a broad range, which may be complicated to
assess while the patient’s life is threatened or
while they are tired, in pain and receiving can-
cer treatment.30 This aspect is controlled by
the fact that the Hospital Anxiety and
Depression scale rules out somatic symptoms
of depression, or in this case somatic symp-
toms possibly resulting from cancer and its
treatment. Results of this study and previous
cancer pain studies are similar to chronic pain
research findings which verify that non-malig-
nant pain has similar associations with mental
health in both inpatient and outpatient set-
tings.11,31,32
Conclusions
The present study provides additional evi-
dence for the role of acceptance in adaptation
to pain interference with function and psycho-
logical distress in cancer outpatients.
Prospective studies could include both outpa-
tients and hospitalized patients to detect any
significant differences in levels of pain and
distress between the two patient categories,33
and how these are influenced by acceptance.
Further prospective confirmation of which
components of pain acceptance predict cancer
patient outcomes would be a step towards
establishing their potential use in acceptance-
based and cognitive-behavioral interventions
for cancer pain. Special focus could be applied
to the potential role of Activity Engagement in
mediating pain interference, anxiety, and
depression.
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